Pharmasyntez Patents – Insights & Stats (Updated 2024)

Pharmasyntez has a total of 125 patents globally, out of which 61 have been granted. Of these 125 patents, more than 72% patents are active. Australia is where Pharmasyntez has filed the maximum number of patents, followed by Russia and United States of America. Parallelly, Russia seems to be the main focused R&D centre and also is the origin country of Pharmasyntez.

Pharmasyntez was founded in 1997. Pharmasyntez is a pharmaceutical company specializing in the development and distribution of cost-effective medications for tuberculosis, HIV, cancer treatment, and blood disorders.

Do read about some of the most popular patents of Pharmasyntez which have been covered by us in this article and also you can find Pharmasyntez patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pharmasyntez patent portfolio.

How many patents does Pharmasyntez have?

Pharmasyntez has a total of 125 patents globally. These patents belong to 23 unique patent families. Out of 125 patents, 91 patents are active.

How Many Patents did Pharmasyntez File Every Year?

Pharmasyntez Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantPharmasyntez Applications FiledPharmasyntez Patents Granted
20241
20233
2022103
2021172
202029
2019417
201812
201713
201626
201532
201417

How many Pharmasyntez patents are Alive/Dead?

Worldwide Patents

How Many Patents did Pharmasyntez File in Different Countries?

Pharmasyntez Worldwide Patent Filing

Countries in which Pharmasyntez Filed Patents

CountryPatent
Australia8
Russia7
United States of America5
Europe (EPO)4
India4
Canada4
China4
Indonesia4
Peru3
Mongolia3
South Africa3
Viet Nam3
New Zealand3
Brazil3
Korea (South)3
Argentina3
Mexico3
Japan3
Philippines2
Colombia2
Austria2
Albania2
Denmark2
Chile2
Portugal2
Israel2
Cuba2
Poland1
Georgia1
Singapore1
Costa Rica1
Germany1
Lithuania1
Dominican Republic1
Malaysia1
Slovenia1
Malta1
Pakistan1
Croatia1
Hong Kong (S.A.R.)1
Spain1
Hungary1
Tunisia1
Serbia1
Eurasian Patent Organization1
Slovakia1
El Salvador1
Nicaragua1
Norway1
Ukraine1
Montenegro1
Uruguay1
Morocco1
Cyprus1
Jordan1

Where are Research Centers of Pharmasyntez Patents Located?

R&D Centres of Pharmasyntez

What are Pharmasyntez key innovation segments?

What Technologies are Covered by Pharmasyntez?

The chart below distributes patents filed by Pharmasyntez in different countries on the basis of the technology protected in patents. It also represents the markets where Pharmasyntez thinks it’s important to protect particular technology inventions.

R&D Focus: How has Pharmasyntez search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Pharmasyntez?

Related Articles

Luzerne Patents – Insights & Stats (Updated 2024)

Luzerne has a total of 9 patents globally, out of which all patents have been granted. Of these 9 patents, all patents are active. Singapore is where Luzerne has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the origin

Read More »

Garena Patents – Insights & Stats (Updated 2024)

Garena has a total of 96 patents globally, out of which 15 have been granted. Of these 96 patents, more than 80% patents are active. Singapore is where Garena has filed the maximum number of patents, followed by United States of America and China. Parallelly, Singapore seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.